Pleuropulmonary blastoma (PPB) is a rare and aggressive pediatric lung cancer originating in the tissues of the lungs and pleura. Cancer research has significantly advanced our understanding of PPB, particularly its genetic underpinnings. Mutations in the DICER1 gene are strongly associated with PPB, providing a genetic marker for early diagnosis and familial screening. Current research is focused on understanding the molecular pathways influenced by DICER1 to develop targeted therapies. Innovative treatment strategies, including personalized medicine and immunotherapy, are being explored to improve outcomes. Despite its rarity, PPB research is pivotal in enhancing survival rates and quality of life for affected children, underscoring the importance of ongoing genetic and therapeutic studies.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States